Ryan Specialty (NYSE:RYAN) Given New $39.00 Price Target at Mizuho

Ryan Specialty (NYSE:RYAN) had its price objective boosted by Mizuho from $35.00 to $39.00 in a report published on Thursday morning, Marketbeat.com reports. The firm currently has a neutral rating on the stock.

Several other research firms have also recently issued reports on RYAN. Cantor Fitzgerald decreased their price objective on shares of Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. UBS Group dropped their target price on Ryan Specialty from $52.00 to $50.00 and set a “buy” rating on the stock in a report on Wednesday. Weiss Ratings restated a “sell (d+)” rating on shares of Ryan Specialty in a research report on Monday, May 4th. Royal Bank Of Canada began coverage on Ryan Specialty in a research note on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price target for the company. Finally, The Goldman Sachs Group lifted their price target on Ryan Specialty from $35.00 to $40.00 and gave the company a “neutral” rating in a research report on Wednesday, July 1st. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and an average price target of $48.59.

Ryan Specialty Trading Down 1.7%

Shares of NYSE:RYAN opened at $40.59 on Thursday. The company has a market cap of $10.70 billion, a PE ratio of 52.72, a P/E/G ratio of 0.99 and a beta of 0.61. The company’s 50-day moving average price is $34.53 and its 200 day moving average price is $39.40. Ryan Specialty has a fifty-two week low of $29.28 and a fifty-two week high of $67.69. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.90.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.43 by $0.04. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. The firm had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. During the same quarter in the prior year, the firm earned $0.39 EPS. Ryan Specialty’s quarterly revenue was up 15.2% on a year-over-year basis. Sell-side analysts anticipate that Ryan Specialty will post 2.05 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were issued a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.3%. The ex-dividend date was Tuesday, May 12th. Ryan Specialty’s payout ratio is currently 67.53%.

Ryan Specialty announced that its board has initiated a share repurchase plan on Tuesday, May 26th that permits the company to buyback $300.00 million in shares. This buyback authorization permits the company to reacquire up to 3.5% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity at Ryan Specialty

In related news, Director John W. Rogers, Jr. acquired 7,500 shares of the stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average price of $35.16 per share, with a total value of $263,700.00. Following the acquisition, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. The trade was a 6.79% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Mark Stephen Katz purchased 3,215 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average cost of $31.07 per share, for a total transaction of $99,890.05. Following the transaction, the executive vice president owned 4,332 shares of the company’s stock, valued at approximately $134,595.24. This trade represents a 287.82% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders bought 130,715 shares of company stock valued at $4,263,590. 52.03% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Ryan Specialty

Several hedge funds have recently modified their holdings of RYAN. Beck Mack & Oliver LLC purchased a new stake in shares of Ryan Specialty during the third quarter valued at $2,818,000. Westview Management dba Westview Investment Advisors purchased a new position in Ryan Specialty in the 4th quarter worth about $2,082,000. SG Americas Securities LLC purchased a new position in Ryan Specialty in the 4th quarter worth about $20,776,000. Stephens Investment Management Group LLC lifted its stake in Ryan Specialty by 41.6% during the 4th quarter. Stephens Investment Management Group LLC now owns 1,929,094 shares of the company’s stock valued at $99,599,000 after acquiring an additional 566,610 shares during the period. Finally, Qsemble Capital Management LP bought a new position in Ryan Specialty during the 4th quarter valued at about $2,823,000. 84.82% of the stock is owned by institutional investors.

Key Ryan Specialty News

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Keefe, Bruyette & Woods raised its price target on Ryan Specialty to $48 from $44 and kept an outperform rating, signaling continued upside potential. Benzinga report
• Positive Sentiment: UBS lifted its target to $50 from $52 and reiterated a buy rating, suggesting analysts still see meaningful upside from current levels. Benzinga report
• Neutral Sentiment: Ryan Specialty announced that Nirvana will acquire certain assets of its Swedish subsidiary, a transaction that appears to be a limited portfolio change rather than a major companywide shift. Article link

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.